- Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enoughS P Althomsons
Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA
Int J Tuberc Lung Dis 16:1331-4. 2012..The worldwide emergence of extensively drug-resistant tuberculosis (TB) has focused attention on treatment with second-line drugs (SLDs)...
- Using routinely reported tuberculosis genotyping and surveillance data to predict tuberculosis outbreaksSandy P Althomsons
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Atlanta, Georgia, United States of America
PLoS ONE 7:e48754. 2012....